Fig. 6: Clinical relevance of GLT8D2-induced FGFR/PI3K activation in human ovarian cancer. | Oncogenesis

Fig. 6: Clinical relevance of GLT8D2-induced FGFR/PI3K activation in human ovarian cancer.

From: Overexpression of glycosyltransferase 8 ___domain containing 2 confers ovarian cancer to CDDP resistance by activating FGFR/PI3K signalling axis

Fig. 6

a Expression analysis the protein expression of GLT8D2, phosphatase levels of FRS2a (Tyr196), AKT (Ser473) and XIAP in 12 freshly collected human ovarian cancer tissue samples (T); GAPDH was used as loading controls. b Correlation analysis of GLT8D2 expression and p-FRS2a (Tyr196), p-AKT (Ser473) and XIAP in 12 freshly collected human ovarian cancer tissue samples (T).

Back to article page